Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Bright Minds Biosciences Inc (DRUG)

Bright Minds Biosciences Inc (DRUG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,833
  • Shares Outstanding, K 4,434
  • Annual Sales, $ 0 K
  • Annual Income, $ -5,470 K
  • 60-Month Beta 1.41
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.12
Trade DRUG with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.0800 +0.93%
on 04/25/24
1.4500 -24.83%
on 04/02/24
-0.1200 (-9.92%)
since 03/25/24
3-Month
1.0800 +0.93%
on 04/25/24
2.3900 -54.39%
on 02/05/24
-0.8200 (-42.93%)
since 01/25/24
52-Week
1.0800 +0.93%
on 04/25/24
6.4400 -83.07%
on 08/08/23
-1.7600 (-61.75%)
since 04/25/23

Most Recent Stories

More News
Bright Minds Announces Non-Brokered Private Placement Fully Subscribed by Management

/CNW/ - Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) ("Bright Minds" or the "Company"), a leading biotechnology company specializing in the...

DRUG.CN : 1.6500 (unch)
DRUG : 1.0900 (unch)
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year’s End

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:CRDF),(NASDAQ:BDRX),(NASDAQ:DRUG),(NYSE:LLY) EQNX::TICKER_END

CRDF : 3.99 (-4.55%)
BDRX : 0.7248 (-3.35%)
DRUG : 1.0900 (unch)
LLY : 724.87 (-1.00%)
PTN : 1.7200 (-0.58%)
Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year's End

/PRNewswire/ -- About 9.4% of the world population is aged 65 or above. Older people typically consume more medicines than the people in other age group...

PTN : 1.7200 (-0.58%)
CRDF : 3.99 (-4.55%)
BDRX : 0.7248 (-3.35%)
DRUG : 1.0900 (unch)
LLY : 724.87 (-1.00%)
New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences

A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same transformational effects as a near-death experience (NDE). The study...

HCA : 314.12 (-1.54%)
DRUG : 1.0900 (unch)
DRUG.CN : 1.6500 (unch)
LFST : 6.16 (-0.16%)
NUMIF : 0.0575 (-3.36%)
NUMI.TO : 0.0800 (unch)
ACHC : 73.38 (+3.08%)
New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences

/PRNewswire/ -- A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking psychedelics can have the same...

NUMI.TO : 0.0800 (unch)
DRUG.CN : 1.6500 (unch)
NUMIF : 0.0575 (-3.36%)
HCA : 314.12 (-1.54%)
DRUG : 1.0900 (unch)
LFST : 6.16 (-0.16%)
ACHC : 73.38 (+3.08%)
New Study Reveals Psychedelic Drugs Can Be Almost as Life-Changing as Near-Death Experiences

FN Media Group Presents Microsmallcap.com Market Commentary   New York, NY – October 5, 2022 –  A new study undertaken by experts at John Hopkins University School of Medicine has revealed that taking...

HCA : 314.12 (-1.54%)
DRUG : 1.0900 (unch)
DRUG.CN : 1.6500 (unch)
LFST : 6.16 (-0.16%)
ACHC : 73.38 (+3.08%)
NUMI.TO : 0.0800 (unch)
NUMIF : 0.0575 (-3.36%)
Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

VANCOUVER, British Columbia, June 27, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE:...

OTC.VN : 0.345 (+1.47%)
DRUG : 1.0900 (unch)
DRUG.CN : 1.6500 (unch)
Bright Minds Biosciences Announces Changes to its Executive Leadership Team, Marking the Transition to a Development Organization

VANCOUVER, British Columbia, June 27, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE:...

OTC.VN : 0.345 (+1.47%)
DRUG : 1.0900 (unch)
DRUG.CN : 1.6500 (unch)
Bright Minds Biosciences to Host Key Opinion Leader Symposium on Dravet Syndrome

-- Review of Phase I ready BMB-101 and upcoming milestones -- -- Webcast to be held on May 19, 2022, 4:00pm ET -- VANCOUVER, British Columbia, May ...

OTC.VN : 0.345 (+1.47%)
DRUG : 1.0900 (unch)
DRUG.CN : 1.6500 (unch)
Bright Minds Biosciences Establishes Scientific Advisory Board, Comprising Five Preeminent Physicians and Scientists Across Mental Health Specialties

-- Herbert Y. Meltzer, MD; Karl Deisseroth, MD, PhD; Robert C. Malenka, MD, PhD; Michael P. Bogenschutz, MD; and Peter Hendricks, PhD, bring decades of...

DRUG.CN : 1.6500 (unch)
DRUG : 1.0900 (unch)
OTC.VN : 0.345 (+1.47%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Bright Minds Biosciences is a biotechnology company. It focused on developing novel drugs for targeted treatment of neuropsychiatric disorders, epilepsy and pain. Bright Minds Biosciences is based in VANCOUVER, British Columbia.

See More

Key Turning Points

3rd Resistance Point 1.1365
2nd Resistance Point 1.1232
1st Resistance Point 1.1066
Last Price 1.0900
1st Support Level 1.0767
2nd Support Level 1.0634
3rd Support Level 1.0468

See More

52-Week High 6.4400
Fibonacci 61.8% 4.3925
Fibonacci 50% 3.7600
Fibonacci 38.2% 3.1275
Last Price 1.0900
52-Week Low 1.0800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar